• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Therapy with progestational agents in advanced benign prostatic hypertrophy.

作者信息

Geller J, Angrist A, Nakao K, Newman H

出版信息

JAMA. 1969 Nov 24;210(8):1421-7.

PMID:4187537
Abstract
摘要

相似文献

1
Therapy with progestational agents in advanced benign prostatic hypertrophy.
JAMA. 1969 Nov 24;210(8):1421-7.
2
Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate.
J Clin Endocrinol Metab. 1967 Apr;27(4):556-60. doi: 10.1210/jcem-27-4-556.
3
[Evaluation of the long-term effect of anti-androgen therapy by sonometrics in patients with benign prostatic hypertrophy].[超声测量法评估抗雄激素治疗对良性前列腺增生患者的长期疗效]
Nihon Hinyokika Gakkai Zasshi. 1988 Oct;79(10):1697-702. doi: 10.5980/jpnjurol1928.79.10_1697.
4
[Clinical effects of chlormadinone acetate (Prostal) on patients with prostatic hypertrophy--with reference to estimation of size and weight of prostate by means of transrectal ultrasonotomography].醋酸氯地孕酮（普罗斯他）对前列腺增生患者的临床疗效——关于经直肠超声断层扫描评估前列腺大小和重量
Hinyokika Kiyo. 1983 Nov;29(11):1419-26.
5
[Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography].抗雄激素治疗后良性前列腺增生患者前列腺形态学变化的临床研究——经直肠超声断层扫描法
Hinyokika Kiyo. 1990 May;36(5):557-60.
6
[Gestagens: a new method of hormonal therapy in benign prostatic hypertrophy].[孕激素：良性前列腺增生症激素治疗的新方法]
Urol Int. 1970;25(3):263-8. doi: 10.1159/000279679.
7
Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.醋酸氯地孕酮和非那雄胺雄激素抑制药物治疗犬自发性良性前列腺增生的组织学组成和细胞凋亡比较
J Urol. 2001 Jan;165(1):289-93. doi: 10.1097/00005392-200101000-00081.
8
[Clinical evaluation of chlormadinone acetate (CMA) in benign prostatic hypertrophy (author's transl)].醋酸氯地孕酮（CMA）治疗良性前列腺增生的临床评价（作者译）
Horumon To Rinsho. 1981 Nov;29(11):1389-94.
9
[Clinical evaluation of the long-term treatment with chlormadinone acetate in patients with benign prostatic hypertrophy].[醋酸氯地孕酮对良性前列腺增生患者的长期治疗的临床评估]
Hinyokika Kiyo. 1993 Mar;39(3):281-7.
10
[Studies of mechanisms of the action of androgens on prostate. 3. Anti-androgenic effect of gestagenic compounds and treatment of benign prostatic hypertrophy with chlormadinone acetate].[雄激素对前列腺作用机制的研究。3. 孕激素类化合物的抗雄激素作用及醋酸氯地孕酮治疗良性前列腺增生]
Nihon Hinyokika Gakkai Zasshi. 1972 Feb;63(2):109-28.

引用本文的文献

1
Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats.雷帕霉素纳米制剂Rapatar可减轻大鼠化学诱导的良性前列腺增生。
Oncotarget. 2015;6(12):9718-27. doi: 10.18632/oncotarget.3929.
2
Shrinking the prostate.缩小前列腺
Br Med J. 1970 Mar 7;1(5696):583.
3
Evaluation of Depostat in prostatic adenoma on the ground of clinical and sphincterotonometric studies.基于临床和括约肌测压研究对Depostat在前列腺腺瘤中的评估。
Int Urol Nephrol. 1971;3(1):21-9. doi: 10.1007/BF02081794.